CytoMed Therapeutics Limited ( GDTC) - Key Metrics
GDTC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q2 | $0.01 | -$0.07 | -$0.05 | -$0.06 |
| 2025Q1 | $0.01 | -$0.07 | -$0.05 | -$0.06 |
| 2024Q4 | $0 | -$0.09 | -$0.05 | -$0.06 |
| 2024Q3 | $0.01 | -$0.05 | -$0.05 | -$0.07 |
GDTC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q2 | ? | -7.53 |
| 2025Q1 | ? | -7.71 |
| 2024Q4 | ? | -9.11 |
| 2024Q3 | ? | -8.15 |
GDTC
Price: $1.03
52 week price:
Earnings Per Share: -0.27 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.3 million